Responses
Clinical and epidemiological research
Extended report
A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study
Compose a Response to This Article
Other responses
No responses have been published for this article.